| Target Price | $102.51 |
| Price | $101.36 |
| Potential |
1.13%
register free of charge
|
| Number of Estimates | 30 |
|
30 Analysts have issued a price target Medtronic 2026 .
The average Medtronic target price is $102.51.
This is
1.13%
register free of charge
$120.75
19.13%
register free of charge
$81.81
19.29%
register free of charge
|
|
| A rating was issued by 39 analysts: 20 Analysts recommend Medtronic to buy, 18 to hold and 1 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the Medtronic stock has an average upside potential 2026 of
1.13%
register free of charge
|
| Apr '25 |
2026 Estimates |
|
|---|---|---|
| Revenue Billion $ | 33.54 | 36.21 |
| 3.62% | 7.97% | |
| EBITDA Margin | 24.99% | 28.81% |
| 3.52% | 15.27% | |
| Net Margin | 13.90% | 20.12% |
| 22.39% | 44.74% |
36 Analysts have issued a sales forecast Medtronic 2026 . The average Medtronic sales estimate is
This results in the following potential growth metrics:
22 Analysts have issued an Medtronic EBITDA forecast 2026. The average Medtronic EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
36 Medtronic Analysts have issued a net profit forecast 2026. The average Medtronic net profit estimate is
This results in the following potential growth metrics and future Net Margins:
| Apr '25 |
2026 Estimates |
|
|---|---|---|
| Earnings Per Share $ | 3.61 | 5.68 |
| 30.80% | 57.34% | |
| P/E | 17.84 | |
| EV/Sales | 4.16 |
36 Analysts have issued a Medtronic forecast for earnings per share. The average Medtronic EPS is
This results in the following potential growth metrics and future valuations:
| Analyst | Rating | Action | Date |
|---|---|---|---|
| Truist Securities |
Locked
➜
Locked
|
Locked | Nov 20 2025 |
| Barclays |
Locked
➜
Locked
|
Locked | Nov 20 2025 |
| RBC Capital |
Locked
➜
Locked
|
Locked | Nov 19 2025 |
| Goldman Sachs |
Locked
➜
Locked
|
Locked | Nov 19 2025 |
| UBS |
Locked
➜
Locked
|
Locked | Nov 19 2025 |
| Morgan Stanley |
Locked
➜
Locked
|
Locked | Nov 19 2025 |
| Baird |
Locked
➜
Locked
|
Locked | Nov 19 2025 |
| Analyst Rating | Date |
|---|---|
|
Locked
Truist Securities:
Locked
➜
Locked
|
Nov 20 2025 |
|
Locked
Barclays:
Locked
➜
Locked
|
Nov 20 2025 |
|
Locked
RBC Capital:
Locked
➜
Locked
|
Nov 19 2025 |
|
Locked
Goldman Sachs:
Locked
➜
Locked
|
Nov 19 2025 |
|
Locked
UBS:
Locked
➜
Locked
|
Nov 19 2025 |
|
Locked
Morgan Stanley:
Locked
➜
Locked
|
Nov 19 2025 |
|
Locked
Baird:
Locked
➜
Locked
|
Nov 19 2025 |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.


